Tamarack Advisers’s Collegium Pharmaceutical COLL Stock Holding History

Tamarack Advisers’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-185,000	Closed	-$4.13M	–	7
2023 Q3	$4.13M	Sell	185,000 -190,000	-51%	-$4.33M	2.68%	11
2023 Q2	$8.06M	Buy	375,000 +20,000	+6%	+$454K	2.49%	6
2023 Q1	$8.52M	Sell	355,000 -32,000	-8%	-$849K	3.11%	8
2022 Q4	$8.98M	Buy	387,000 +87,000	+29%	+$1.75M	4.62%	7
2022 Q3	$4.81M	Buy	300,000 +200,000	+200%	+$3.53M	2.82%	16
2022 Q2	$1.77M	Buy	+100,000	New	+$1.68M	1.03%	25
2016 Q3	–	Sell	-94,908	Closed	-$1.13M	–	39
2016 Q2	$1.13M	Buy	+94,908	New	+$1.57M	0.43%	26

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Tamarack Advisers's COLL Position: Q4 2023 in Review

Tamarack Advisers sold out of Collegium Pharmaceutical (COLL) in Q4 2023, closing a stake of 185,000 shares — an estimated $4.13M sold.

Tamarack Advisers first reported a position in COLL in Q2 2016 and held it in 7 quarters. The position peaked at $8.98M in Q4 2022. 193 funds tracked by Wall St. Rank hold COLL as of Q4 2023.

Tamarack Advisers reported no remaining Collegium Pharmaceutical position as of Q4 2023 after selling out during the quarter.
Tamarack Advisers sold 185,000 Collegium Pharmaceutical shares in Q4 2023, an estimated $4.13M.
Tamarack Advisers first reported a position in Collegium Pharmaceutical in Q2 2016 and held it in 7 quarters.
Tamarack Advisers's Collegium Pharmaceutical position peaked at $8.98M in Q4 2022.
193 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2023.

Based on Tamarack Advisers's 13F filing for Q4 2023, filed 9 Feb 2024.